Hyperlipidemia in Primary Care

1. Front Matter

   Pages i-xi

   PDF

2. Cardiovascular Risk Assessment

   • Matthew J. Sorrentino

   Pages 1-11

3. The Metabolic Syndrome

   • Matthew J. Sorrentino

   Pages 13-39

4. The Role of Imaging in Cardiovascular Risk Assessment

   • Tamar S. Polonsky, R. Parker Ward

   Pages 41-55

5. Inherited Lipoprotein Disorders

   • Ewa Dembowski, Michael H. Davidson

   Pages 57-75

6. Advanced Lipid Testing

   • Matthew J. Sorrentino

   Pages 77-103

7. Therapeutic Lifestyle Change for the Prevention and Treatment of Hyperlipidemia and Coronary Artery Disease

   • Rajesh Gupta, Bashar Almadani, Neil Stone

   Pages 105-120

8. Drug Therapy for Dyslipidemia

   • Matthew J. Sorrentino

   Pages 121-139

9. Hypertriglyceridemia

   • Sonal Chandra, Matthew J. Sorrentino

   Pages 141-158

10. Isolated Low HDL

    • Robert S. Rosenson

    Pages 159-171

11. Lipoprotein(a)

    • Matthew J. Sorrentino

    Pages 173-179

12. HIV with Dyslipidemia

    • Tochi Okwuosa

    Pages 181-204

13. Treatment of Dyslipidemia in Patients with Renal Insufficiency and End-Stage Renal Disease

    • Matthew J. Sorrentino

    Pages 205-218

14. Back Matter

    Pages 219-228

    PDF

Cardiovascular disease is the number one cause of death for men and women in this country, surpassing deaths due to all cancers combined. Better awareness of heart disease risk factors and improved treatment modalities has produced great progress in reducing deaths due to myocardial infarction and stroke over the past few decades.  Still, more progress is needed, as about half of all first coronary events occur in individuals who have no cardiac symptoms and no previously diagnosed heart disease.  The primary care physician, therefore, has an important role in identifying at risk individuals and beginning preventive modalities.   In Hyperlipidemia in Primary Care: A Practical Guide to Risk Reduction, a group of leading authorities in the field offers a comprehensive overview of the problem along with practical strategies for treating it.   This unique title reviews methods for assessing risk in patients, including an important and thorough discussion of the Framingham algorithmand its limitations and advantages in assessing CVD risk.    The book also reviews the evolving world of lipidology and how to apply many of the newer lipid tests to patients in daily practice, putting these tests into proper perspective and offering a rational approach to using them in practice.   Finally, treatment issues are covered.   As treatment has expanded to more risk groups, a number of different guidelines have been published with recommended lipid goals. This is an evolving area of research with rapidly changing guidelines that are expanding the pool of high risk patients.   An invaluable reference that offers a reasonable approach to risk assessment and treatment of individuals at increased cardiovascular risk, Hyperlipidemia in Primary Care: A Practical Guide to Risk Reduction provides the background needed to make scientifically based decisions that can ultimately help greatly reduce the number of patients impacted by cardiovascular  disease.

From the reviews:

“This is one of a number of books addressing the single topic of hyperlipidemia. The strength of this one lies in its extensive literature review and analysis. … While this book is aimed at clinicians who commonly treat patients with hyperlipidemia, it is so well organized and easy to understand that it will be useful for laypersons who have been diagnosed with some component of hyperlipidemia … . I highly recommend this book to all who treat patients with dyslipidemia.” (Vincent F. Carr, Doody’s Book Reviews, November, 2011)

• Pritzker School of Medicine, Department of Medicine, University of Chicago, Chicago, USA

  Matthew J. Sorrentino

Policies and ethics